NCT03865680View on ClinicalTrials.gov

Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish on Remineralization of White Spot Lesion in Primary Teeth

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 28, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

April 10, 2020

Conditions
White Spot Lesion
Interventions
DRUG

CPP-ACP

The fluoride varnish applications will be applied with identical intensive protocols every 2 weeks for 6 weeks. The application of will be according to manufacturer's instructions.

DRUG

Duraphat

The fluoride varnish applications will be applied with identical intensive protocols every 2 weeks for 6 weeks. The application of will be according to manufacturer's instructions.

Trial Locations (1)

21512

Faculty of Dentistry, Alexandria University, Alexandria

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Nourhan M.Aly

OTHER

NCT03865680 - Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish on Remineralization of White Spot Lesion in Primary Teeth | Biotech Hunter | Biotech Hunter